Also known as: Alitretinoin 9-cis-retinoic acid
Alitretinoin is a naturally-occurring endogenous hormone related to vitamin A, binds to and activates all known intracellular retinoid receptor subtypes (RAR, RAR, RAR, RXR, RXR, RXR). The efficacy of alitretinoin in treating KS lesions may be related to the demonstrated ability of alitretinoin to inhibit the in vitro growth of KS cells.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Alitretinoin is the active ingredient of these drugs:
Austria
France Netherlands
Estonia Lithuania Poland United States
Austria Canada Estonia Finland France
New Zealand
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):